Literature DB >> 15109686

New training strategies for constructive neural networks with application to regression problems.

L Ma1, K Khorasani.   

Abstract

Regression problem is an important application area for neural networks (NNs). Among a large number of existing NN architectures, the feedforward NN (FNN) paradigm is one of the most widely used structures. Although one-hidden-layer feedforward neural networks (OHL-FNNs) have simple structures, they possess interesting representational and learning capabilities. In this paper, we are interested particularly in incremental constructive training of OHL-FNNs. In the proposed incremental constructive training schemes for an OHL-FNN, input-side training and output-side training may be separated in order to reduce the training time. A new technique is proposed to scale the error signal during the constructive learning process to improve the input-side training efficiency and to obtain better generalization performance. Two pruning methods for removing the input-side redundant connections have also been applied. Numerical simulations demonstrate the potential and advantages of the proposed strategies when compared to other existing techniques in the literature.

Mesh:

Year:  2004        PMID: 15109686     DOI: 10.1016/j.neunet.2004.02.002

Source DB:  PubMed          Journal:  Neural Netw        ISSN: 0893-6080


  3 in total

1.  Forecasting model for the incidence of hepatitis A based on artificial neural network.

Authors:  Peng Guan; De-Sheng Huang; Bao-Sen Zhou
Journal:  World J Gastroenterol       Date:  2004-12-15       Impact factor: 5.742

2.  Artificial neural networks for diagnosis and survival prediction in colon cancer.

Authors:  Farid E Ahmed
Journal:  Mol Cancer       Date:  2005-08-06       Impact factor: 27.401

3.  The development of a combined mathematical model to forecast the incidence of hepatitis E in Shanghai, China.

Authors:  Hong Ren; Jian Li; Zheng-An Yuan; Jia-Yu Hu; Yan Yu; Yi-Han Lu
Journal:  BMC Infect Dis       Date:  2013-09-08       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.